Equities

Earlier this week Catapult provided an update of sorts and we have outlined the key points.

We have lifted our near-term lithium price outlook, and have increased our price target to $20.04 per share, up from $18.76 per share for Allkem.

We have reviewed our forecasts post the release of the FY22 result last month for Altium (ALU) and put through modest revenue and EBITDA upgrades of 1%, 2% and 3% in FY23, FY24 and FY25.

We have conducted an analysis of recent data points we monitor for Nufarm (NUF) as indicators of activity.

We have initiated coverage on Cronos Australia, a medicinal cannabis company that is the market leader in distribution to pharmacies and provides patient consulting services through its clinic business.

Our analysts provide their sector outlook and top stock picks for FY23.